NRGN and myeloid sarcoma: Within MS patients, CSF neurogranin has been found to be higher in those with gadolinium enhancing lesions compared to those without [92], confirming the evidence that acute inflammation in MS can be associated with synaptic damage and with subsequent transient increase in CSF neurogranin concentrations.